Login

Ben McMillan, CIO of IDX Digital Assets, discusses this week's crypto market volatility and its potential implications. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Bokusgruppen's CEO Maria Edsman on Last Quarter's Performance and New Financial Goals | Maria Edsman, CEO, Bokusgruppen AB.
00:10:00
This is how a successful IT career began in Salzburg | Peter Belly, Managing Director, B+S Banksysteme AGDTD2X:GER
00:10:00
Living with Purpose: Inspiring Youth and Transforming Communities | William H. Rogers Jr, Chairman ,  Truist Financial.
00:10:00
Serge Van Herck, CEO of EVS, presents at IBC2023.
00:10:00
Smart Money: Funding and Exit Trends|Anna Fang,investor,ZhenFund
00:10:00
Advancing Water Management Amidst Climate Challenges: Cadiz Inc.'s Evolution and Strategic Solutions | Susan Kennedy, CEO, Cadiz Inc .
00:10:00
Educational Quality and Economic Growth: Insights from OECD Study|Ludger Wößmann
00:10:00
Jim Russo on Market Selloff Amid Omicron Fears, Inflation, and Fed Comments | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Strategic Cyber Ventures is the industry|Hank Thomas,CEO & Founder,Strategic Cyber Ventures
00:10:00
Vind Sidhu of Pestech Energy Sdn Bhd joins NCT Tech Talk EP10, featuring insights from the Sales and Marketing Manager of NCT Group of Companies.
00:10:00
Q3-2022 Financial Highlights with Sebastian Lehmann, Head of Investor Relations | EDAG Engineering AG
00:00:00
AEterna Zentaris Inc is a specialty biopharmaceutical company - Klaus Paulini, PhD President and Chief Executive Officer, Aeterna Zentaris, Inc.

© 2017 - Neuhu+